Skadden advised Goldman Sachs (Asia) L.L.C., China International Capital Corporation Hong Kong Securities Limited and Credit Suisse (Hong Kong) Limited as lead underwriters on the IPO….
Clover Biopharmaceuticals’ US$257.8 Million Hong Kong Initial Public Offering
